The Latest Cardiac and Vascular News
ALISO VIEJO, Calif., May 31, 2018 /PRNewswire/ — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms. The LVIS® and LVIS® Jr. stents are the first and only stents PMA approved for stent-assisted coil embolization and only […]
TOKYO, JAPAN – April 24, 2018 – Terumo Aortic announced the European limited market release of the RelayPro Thoracic Stent-Graft System at the 2018 Charing Cross conference. RelayPro is a low profile, next generation device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels. Utilising the same […]
New company brings together two leaders in the aortic implant market New identity underlines global growth ambitions further to $43m factory investment Merger unites two world-class innovators focused on expanding aortic treatment options Vascutek and Bolton Medical have combined into a single business as it looks to grow its presence in the global aortic and […]
DUBLIN–(BUSINESS WIRE)–The “Transradial Access Market by Product (Catheters, Guidewires, Sheath and Sheath Introducers), Application (Administration of Medicine and Administration of fluids), End User (Hospitals, Clinics & Ambulatory Centres) – Global Forecast 2022” report has been added to ResearchAndMarkets.com’s offering. The Global Transradial Access Devices Market is Expected to Grow at a CAGR of 7.5% to Reach to USD 2.18 […]
ALISO VIEJO, Calif., Sept. 26, 2017 /PRNewswire/ — MicroVention, a wholly owned subsidiary of Terumo Corporation and a global neurovascular company, today announced that the Grand Opening of its New Innovation Center was held on Monday, September 25. The opening of the new facility, located in the heart of the Summit Office Campus, also signifies the Company’s official return […]
TOKYO, JAPAN – September 19, 2017 – Terumo Corporation (TSE: 4543) announced today that it has launched QuiremSpheres® microspheres on September 18 in Europe. QuiremSpheres® are available in Europe with plans for expansion its sales area outside of Europe in the future. QuiremSpheres®, the next generation of SIRT microspheres, are indicated for the treatment of […]
ANN ARBOR, Mich., April 6, 2017 /PRNewswire/ — Terumo Cardiovascular (CV) Group today announced that Robert (Rob) DeRyke has been appointed President and CEO of Terumo CV Group, effective April 1, 2017, following the retirement of long-time President and CEO Mark Sutter. In this position, DeRyke will lead Terumo’s global business related to the cardiopulmonary bypass […]
